-
Race for a COVID-19 Vaccine: Will Emerging Economies Be Left Behind?
As various countries contend with a second wave of Covid-19 outbreaks, many emerging markets are pinning their hopes on a vaccine that will allow them to confidently reopen their economies without the fear of health services being overwhelmed.
- Categories
- Coronavirus, Health Care
-
Bill Gates Is Spending $150 Million to Try to Make a Coronavirus Vaccine as Cheap as $3
Pay more attention to what Gates is doing overseas than what he’s saying about the United States.
- Categories
- Coronavirus, Health Care, Investing
- Tags
- impact investing, vaccines
-
Global COVID-19 Impact on Vaccines & Drugs Market Growth Is Mainly Attributed Due to Growing Number of People Infected With COVID-19 and Rising Funding for Vaccine Development – PMI
Technological advancements in the pharmaceutical sector comprising the development of nucleic acid vaccines that are DNA- and RNA-based, and which allow the human body to produce vaccine antigen. Such initiatives and activities are expected to support market growth to a substantial extent.
- Categories
- Coronavirus, Technology
- Tags
- vaccines
-
Viewpoint: Why Tech Didn’t Save Us From COVID-19
America's paralysis reveals a deep and fundamental flaw in how the nation thinks about innovation.
- Categories
- Coronavirus, Finance, Health Care, Technology
-
Report: Countries, Companies Risk Billions in Race for Coronavirus Vaccine
“The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop,” said Paul Stoffels, chief scientific officer at Johnson & Johnson, which has partnered with the U.S. government on a $1 billion investment to speed development and production of its still-unproven vaccine. “If it fails,” Stoffels told Reuters, “it will be bad.”
- Categories
- Coronavirus, Health Care
- Region
- North America
- Tags
- public health, vaccines
-
Big Pharma’s Blindspot: Before COVID-19, Vaccine and Antiviral Research Went Neglected
Public health experts have warned for years that the world is at risk of a major pandemic, and advocates say Big Pharma showed little interest in developing vaccines — or even antibiotic and antiviral medications — until the latest outbreak offered an opportunity to rake in public funding and turn out massive profits with minimal risk.
- Categories
- Coronavirus, Health Care
- Tags
- public health, research, vaccines
-
Gates Foundation’s Efforts to Fight Coronavirus, Explained
The Gates Foundation has emerged as a leader in the coronavirus response.
- Categories
- Coronavirus
- Region
- North America
-
Viewpoint: How to Make a Faster Coronavirus Vaccine
Emergency funding, hard work and ingenuity could well result in a relatively speedy vaccine. But the amount of uncertainty in that outcome and the death toll that will mount even in a best-case scenario suggest a need for a far more ambitious intervention.
- Categories
- Coronavirus, Health Care
- Tags
- public health, vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.